Current Development of Monoclonal Antibodies in Cancer Therapy
Exploiting the unique specificity of monoclonal antibodies has revolutionized the treatment and diagnosis of haematological and solid organ malignancies; bringing benefit to millions of patients over the past decades. Recent achievements include conjugating antibodies with toxic payloads resulting i...
Saved in:
Published in | Recent results in cancer research Vol. 214; p. 1 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Germany
2020
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Exploiting the unique specificity of monoclonal antibodies has revolutionized the treatment and diagnosis of haematological and solid organ malignancies; bringing benefit to millions of patients over the past decades. Recent achievements include conjugating antibodies with toxic payloads resulting in superior efficacy and/or reduced toxicity, development of molecular imaging techniques targeting specific antigens for use as predictive and prognostic biomarkers, the development of novel bi- and tri-specific antibodies to enhance therapeutic benefit and abrogate resistance and the success of immunotherapy agents. In this chapter, we review an overview of antibody structure and function relevant to cancer therapy and provide an overview of pivotal clinical trials which have led to regulatory approval of monoclonal antibodies in cancer treatment. We further discuss resistance mechanisms and the unique side effects of each class of antibody and provide an overview of emerging therapeutic agents. |
---|---|
AbstractList | Exploiting the unique specificity of monoclonal antibodies has revolutionized the treatment and diagnosis of haematological and solid organ malignancies; bringing benefit to millions of patients over the past decades. Recent achievements include conjugating antibodies with toxic payloads resulting in superior efficacy and/or reduced toxicity, development of molecular imaging techniques targeting specific antigens for use as predictive and prognostic biomarkers, the development of novel bi- and tri-specific antibodies to enhance therapeutic benefit and abrogate resistance and the success of immunotherapy agents. In this chapter, we review an overview of antibody structure and function relevant to cancer therapy and provide an overview of pivotal clinical trials which have led to regulatory approval of monoclonal antibodies in cancer treatment. We further discuss resistance mechanisms and the unique side effects of each class of antibody and provide an overview of emerging therapeutic agents. |
Author | King, Dylan Gan, Hui K Scott, Andrew M Parakh, Sagun |
Author_xml | – sequence: 1 givenname: Sagun surname: Parakh fullname: Parakh, Sagun organization: School of Cancer Medicine, La Trobe University, Melbourne, Australia – sequence: 2 givenname: Dylan surname: King fullname: King, Dylan organization: School of Cancer Medicine, La Trobe University, Melbourne, Australia – sequence: 3 givenname: Hui K surname: Gan fullname: Gan, Hui K organization: School of Cancer Medicine, La Trobe University, Melbourne, Australia – sequence: 4 givenname: Andrew M surname: Scott fullname: Scott, Andrew M email: andrew.scott@onjcri.org.au, andrew.scott@onjcri.org.au, andrew.scott@onjcri.org.au, andrew.scott@onjcri.org.au organization: Department of Medicine, University of Melbourne, Melbourne, Australia. andrew.scott@onjcri.org.au |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31473848$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j8tOwzAURL0ooqXtFyAh_4Dh-u1skKrwlIq6KevIcW5EUGJHTovUv6cImM2c1ejMFZnFFJGQaw63HMDeFdYxyUACE9IazWTFZ2QB4IABcD0n62n6hHO0kcK4SzKXXFnplFuQ-_KYM8YDfcAv7NM4_HBq6VuKKfQp-p5u4qGrU9PhRLtISx8DZrr_wOzH04pctL6fcP3XS_L-9LgvX9h29_xabrYsCF1w1nBtoBAhGOFNobHVqBsu0Yva1hYtKuVa29SqCGdrqaTwqgXwErwJ3BuxJDe_u-OxHrCpxtwNPp-q_yPiG4OaStc |
CitedBy_id | crossref_primary_10_3389_fonc_2022_904790 crossref_primary_10_5604_01_3001_0014_8889 crossref_primary_10_3390_cancers14040911 crossref_primary_10_3390_ijms241612623 crossref_primary_10_1002_btm2_10677 crossref_primary_10_1080_1061186X_2023_2295803 crossref_primary_10_1096_fj_202001203R crossref_primary_10_1155_2021_5569590 crossref_primary_10_1111_imm_13636 crossref_primary_10_3390_cancers12061504 crossref_primary_10_3390_vaccines8030537 crossref_primary_10_1371_journal_pone_0264822 crossref_primary_10_1016_j_clinthera_2023_10_016 crossref_primary_10_3389_fbioe_2021_795300 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1007/978-3-030-23765-3_1 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
ExternalDocumentID | 31473848 |
Genre | Journal Article Review |
GroupedDBID | --- 29P 3O- 53G 5RE ABCQX ALMA_UNASSIGNED_HOLDINGS AMKLP CGR CUY CVF ECM EIF L7B NPM RIG RSU X7N |
ID | FETCH-LOGICAL-c2591-d156092cc62a695ef5e5d13ea2b7b7e7e448f7db49c0803432a4f00a30a6c1a62 |
ISSN | 0080-0015 |
IngestDate | Wed Oct 16 00:52:28 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c2591-d156092cc62a695ef5e5d13ea2b7b7e7e448f7db49c0803432a4f00a30a6c1a62 |
PMID | 31473848 |
ParticipantIDs | pubmed_primary_31473848 |
PublicationCentury | 2000 |
PublicationDate | 2020-00-00 |
PublicationDateYYYYMMDD | 2020-01-01 |
PublicationDate_xml | – year: 2020 text: 2020-00-00 |
PublicationDecade | 2020 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany |
PublicationTitle | Recent results in cancer research |
PublicationTitleAlternate | Recent Results Cancer Res |
PublicationYear | 2020 |
SSID | ssj0000563268 |
Score | 2.317982 |
SecondaryResourceType | review_article |
Snippet | Exploiting the unique specificity of monoclonal antibodies has revolutionized the treatment and diagnosis of haematological and solid organ malignancies;... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 1 |
SubjectTerms | Antibodies, Monoclonal - pharmacology Clinical Trials as Topic Humans Immunotherapy Neoplasms - therapy |
Title | Current Development of Monoclonal Antibodies in Cancer Therapy |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31473848 |
Volume | 214 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1da9swFBXNCiUvZf3Y1rUbetjbULFlWZZfCqXtGgotfUigb0Ff3sIyO4Tkof31u7Lkj4Z2bHsxxhLG9j2-1r055wShLzpilsa8IMZoS1iqcqKUUCSmkTaCMSOMEzjf3vHRhN08pA-dhKBWl6zUqX56UVfyP1GFYxBXp5L9h8i2J4UDsA_xhS1EGLZ_FePGXKnH_KkpLVVZ6Xnd4jsvVzNVOaZgLe9zIV46lkXrJNB4c1vH0vwKtfd6vqrnaj83mAG1TeN7uZQ_f_he8vd17yd8nzMuH-cd3K59c3W0nvWaqTowRDyTMjRjQ9uBRr22Q0ilwknSvRazSaU0Zr1kGL-YovusDMgwxNFyUpJMn82G57z4VUctiVmWCO_G-efRDd_sZmiABplwue8u9HG86zuHdav_TIf7aC2pvOvwxsUN0U5zwo0CpF6IjN-i3VBB4HMPhz20Zct9tHMbOBIH6CygAvdQgasCd6jAHSrwrMQeFTig4hBNvl2NL0Yk_EsG0VC6xsQ4LXxOteZU8jy1RWpTEydWUpWpzGYWCvAiM4rlzlTe6YglK6JIJpHkOpacvkNvyqq0HxDmTFEtioRLkzNpqIDyQSRZAqtSanSeHaH3_s6nC2-FMm2eycdXR47RsIPPCdou4N2zn2Aht1Kf65j8Bgv0Qdk |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Current+Development+of+Monoclonal+Antibodies+in+Cancer+Therapy&rft.jtitle=Recent+results+in+cancer+research&rft.au=Parakh%2C+Sagun&rft.au=King%2C+Dylan&rft.au=Gan%2C+Hui+K&rft.au=Scott%2C+Andrew+M&rft.date=2020-01-01&rft.issn=0080-0015&rft.volume=214&rft.spage=1&rft_id=info:doi/10.1007%2F978-3-030-23765-3_1&rft_id=info%3Apmid%2F31473848&rft_id=info%3Apmid%2F31473848&rft.externalDocID=31473848 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0080-0015&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0080-0015&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0080-0015&client=summon |